Cardio-Renal-Metabolic Outcomes Associated With the Use of GLP-1 Receptor Agonists After Heart Transplantation

Donald, E. M., Driggin, E., Choe, J., Batra, J., Vargas, F., Lindekens, J., Fried, J. A., Raikhelkar, J. K., Bae, D. J., Oh, K. T., Yuzefpolskaya, M., Colombo, P. C., Latif, F., Sayer, G., Uriel, N., Clerkin, K. J., & DeFilippis, E. M. (2024). Cardio‐Renal‐Metabolic Outcomes Associated With the Use of GLP‐1 Receptor Agonists After Heart Transplantation. Clinical Transplantation, 38(7). Portico. https://doi.org/10.1111/ctr.15401
Authors:
Elena M Donald
Elissa Driggin
Jason Choe
Jaya Batra
Fabian Vargas
Jordan Lindekens
Justin A Fried
Jayant K Raikhelkar
David J Bae
Kyung T Oh
Melana Yuzefpolskaya
Paolo C Colombo
Farhana Latif
Gabriel Sayer
Nir Uriel
Kevin J Clerkin
Ersilia M DeFilippis
Affiliated Authors:
Elena M Donald
Elissa Driggin
Jason Choe
Jaya Batra
Fabian Vargas
Jordan Lindekens
Justin A Fried
Jayant K Raikhelkar
David J Bae
Kyung T Oh
Melana Yuzefpolskaya
Paolo C Colombo
Farhana Latif
Gabriel Sayer
Nir Uriel
Kevin J Clerkin
Ersilia M DeFilippis
Author Keywords:
diabetes
glucagon-like peptide 1
heart transplantation
obesity
weight loss
glucagon‐like peptide 1
Publication Type:
Article
Unique ID:
10.1111/ctr.15401
PMID:
Publication Date:
Data Source:
PubMed

Record Created: